X
Allergan buys Bonti and its Botox successor, as biosimilar looms
https://pharmaphorum.com/news/allergan-buys-bonti-and-its-botox-successor-as-biosimilar-looms/
biosimilar
Biosimilars underused in rheumatoid arthritis on the NHS – experts
Experts call for lower disease activity threshold for biologic drugs
Mylan to market Lupin’s Enbrel biosimilar outside US
Lupin’s biosimilar is under review in EU
EC to update IP rules to benefit generic exports
The European Commission (EC) is proposing to adjust intellectual property (IP) rules to help Europe’s pharma companies tap into fast-growing global markets.
